Martin Helsing

506 total citations
17 papers, 394 citations indexed

About

Martin Helsing is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Martin Helsing has authored 17 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 3 papers in Surgery. Recurrent topics in Martin Helsing's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Lung Cancer Research Studies (5 papers). Martin Helsing is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Lung Cancer Research Studies (5 papers). Martin Helsing collaborates with scholars based in Sweden, Germany and United Kingdom. Martin Helsing's co-authors include Lars Thaning, Bengt Bergman, M. Kaufmann, K. Possinger, U. Ohnmacht, M. Arning, Robert Coleman, Roger Henriksson, Rolf Zimmerman and S. Colleen and has published in prestigious journals such as Cancer, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Martin Helsing

16 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Helsing Sweden 9 275 167 89 54 49 17 394
Burton Needles United States 10 330 1.2× 104 0.6× 48 0.5× 151 2.8× 41 0.8× 17 544
Arzu Oğuz Türkiye 9 205 0.7× 60 0.4× 63 0.7× 53 1.0× 39 0.8× 36 310
Matthew Perry United States 8 294 1.1× 136 0.8× 83 0.9× 21 0.4× 65 1.3× 13 458
A. Chemaissani Germany 9 464 1.7× 508 3.0× 37 0.4× 72 1.3× 124 2.5× 13 650
Philippe Rochigneux France 14 406 1.5× 132 0.8× 79 0.9× 60 1.1× 97 2.0× 39 649
L.S. McGinnis United States 6 263 1.0× 85 0.5× 64 0.7× 106 2.0× 33 0.7× 9 461
Prashant Gabani United States 12 156 0.6× 188 1.1× 63 0.7× 60 1.1× 29 0.6× 28 342
M. Sassi Italy 7 361 1.3× 345 2.1× 78 0.9× 62 1.1× 65 1.3× 9 529
R. Blanco Spain 9 282 1.0× 227 1.4× 44 0.5× 68 1.3× 47 1.0× 12 511
S Schryber United States 8 258 0.9× 77 0.5× 107 1.2× 43 0.8× 76 1.6× 9 435

Countries citing papers authored by Martin Helsing

Since Specialization
Citations

This map shows the geographic impact of Martin Helsing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Helsing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Helsing more than expected).

Fields of papers citing papers by Martin Helsing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Helsing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Helsing. The network helps show where Martin Helsing may publish in the future.

Co-authorship network of co-authors of Martin Helsing

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Helsing. A scholar is included among the top collaborators of Martin Helsing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Helsing. Martin Helsing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Holgersson, Georg, Michael Bergqvist, Simon Ekman, et al.. (2012). Swedish Lung Cancer Radiation Study Group: Predictive value of age at diagnosis for radiotherapy response in patients with non-small cell lung cancer. Acta Oncologica. 51(6). 759–767. 4 indexed citations
2.
Holgersson, Georg, Michael Bergqvist, Jan Nyman, et al.. (2012). The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer. Medical Oncology. 30(1). 320–320. 3 indexed citations
3.
Holgersson, Georg, Martin Sandelin, Stefan Bergström, et al.. (2012). Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer. Medical Oncology. 29(5). 3176–3182. 57 indexed citations
4.
Holgersson, Georg, Martin Sandelin, Stefan Bergström, et al.. (2012). The value of induction chemotherapy for survival in patients with non-small cell lung cancer treated with radiotherapy.. PubMed. 32(4). 1339–46. 1 indexed citations
5.
Holgersson, Georg, Stefan Bergström, Michael Bergqvist, et al.. (2011). Swedish Lung Cancer Radiation Study Group: Predictive value of histology for radiotherapy response in patients with non-small cell lung cancer. European Journal of Cancer. 47(16). 2415–2421. 10 indexed citations
6.
Rawal, Narinder, et al.. (2006). Pain relief following breast augmentation surgery: a comparison between incisional patient-controlled regional analgesia and traditional oral analgesia. European Journal of Anaesthesiology. 23(12). 1010–1017. 25 indexed citations
7.
Fernandes, Oswaldo, Lars Thaning, Derek Filbey, et al.. (2003). Prognostic Factors for the Survival of Surgically Treated Patients for Non-Small Cell Lung Cancer. Acta Oncologica. 42(4). 338–341. 11 indexed citations
8.
Helsing, Martin, Lars Thaning, Christer Sederholm, et al.. (1999). Treatment with paclitaxel 1-h infusion and carboplatin of patients with advanced non-small-cell lung cancer: a phase II multicentre trial. Lung Cancer. 24(2). 107–113. 9 indexed citations
9.
Possinger, K., M. Kaufmann, Robert Coleman, et al.. (1999). Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer. Anti-Cancer Drugs. 10(2). 155–162. 107 indexed citations
10.
Henriksson, Roger, et al.. (1998). Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, α-interferon (leucocyte) and tamoxifen. British Journal of Cancer. 77(8). 1311–1317. 42 indexed citations
11.
12.
Helsing, Martin. (1997). Trofosfamide as a salvage treatment with low toxicity in malignant lymphoma. A phase II study. European Journal of Cancer. 33(3). 500–502. 18 indexed citations
13.
14.
Helsing, Martin. (1997). Trofosfamide as a Salvage Treatment with Low Toxicity in Malignant Lymphoma. A Phase II Study. European Journal of Cancer. 33(3). 500–502. 1 indexed citations
15.
Henriksson, Roger, Susan K. Nilsson, S. Colleen, et al.. (1997). Survival in renal cell carcinoma (RCC)— A randomised evaluation of tamoxifen versus interleukin-2, α-interferon (leukocyte) and tamoxifen. European Journal of Cancer. 33. S37–S37. 1 indexed citations
16.
Possinger, K., M. Kaufmann, Martin Helsing, Robert E. Coleman, & J. Blatter. (1995). 369 Advanced breast cancer: A phase II trial with gemcitabine (GEM). European Journal of Cancer. 31. S80–S80. 2 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Burton Needles Breakdown of academic impact, for papers by Arzu Oğuz Breakdown of academic impact, for papers by Matthew Perry Breakdown of academic impact, for papers by A. Chemaissani Breakdown of academic impact, for papers by Philippe Rochigneux Breakdown of academic impact, for papers by L.S. McGinnis Breakdown of academic impact, for papers by Prashant Gabani Breakdown of academic impact, for papers by M. Sassi Breakdown of academic impact, for papers by R. Blanco Breakdown of academic impact, for papers by S Schryber
Rankless by CCL
2026